BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26404045)

  • 1. [V Consensus Meeting of the Spanish Society for Liver Transplant on high-risk recipients, immunosupression scenarios and management of hepatocarcinoma on the transplant waiting list].
    Pardo F; Pons JA; Briceño J;
    Gastroenterol Hepatol; 2015 Dec; 38(10):600-18. PubMed ID: 26404045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. V Consensus Meeting of the Spanish Society for Liver Transplant on high-risk recipients, immunosupression scenarios and management of hepatocarcinoma on the transplant waiting list.
    Pardo F; Pons JA; Briceño J;
    Cir Esp; 2015 Dec; 93(10):619-37. PubMed ID: 26187597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VI consensus document by the Spanish Liver Transplantation Society.
    Pardo F; Pons JA; Castells L; Colmenero J; Gómez MÁ; Lladó L; Pérez B; Prieto M; Briceño J
    Gastroenterol Hepatol; 2018; 41(6):406-421. PubMed ID: 29866511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VI consensus document by the Spanish Liver Transplantation Society.
    Pardo F; Pons JA; Castells L; Colmenero J; Gómez MÁ; Lladó L; Pérez B; Prieto M; Briceño J
    Cir Esp (Engl Ed); 2018; 96(6):326-341. PubMed ID: 29776591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific issues concerning the management of patients on the waiting list and after liver transplantation.
    Burra P; Giannini EG; Caraceni P; Ginanni Corradini S; Rendina M; Volpes R; Toniutto P
    Liver Int; 2018 Aug; 38(8):1338-1362. PubMed ID: 29637743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients.
    Charlton M; Levitsky J; Aqel B; OʼGrady J; Hemibach J; Rinella M; Fung J; Ghabril M; Thomason R; Burra P; Little EC; Berenguer M; Shaked A; Trotter J; Roberts J; Rodriguez-Davalos M; Rela M; Pomfret E; Heyrend C; Gallegos-Orozco J; Saliba F
    Transplantation; 2018 May; 102(5):727-743. PubMed ID: 29485508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Impact and Risk Factors of Portal Vein Thrombosis for Patients on Wait List for Liver Transplant.
    Montenovo M; Rahnemai-Azar A; Reyes J; Perkins J
    Exp Clin Transplant; 2018 Apr; 16(2):166-171. PubMed ID: 28621635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates.
    Terrault NA; McCaughan GW; Curry MP; Gane E; Fagiuoli S; Fung JYY; Agarwal K; Lilly L; Strasser SI; Brown KA; Gadano A; Kwo PY; Burra P; Samuel D; Charlton M; Pessoa MG; Berenguer M
    Transplantation; 2017 May; 101(5):945-955. PubMed ID: 28437387
    [No Abstract]   [Full Text] [Related]  

  • 9. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
    Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
    J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation.
    Piscaglia F; Gianstefani A; Ravaioli M; Golfieri R; Cappelli A; Giampalma E; Sagrini E; Imbriaco G; Pinna AD; Bolondi L;
    Liver Transpl; 2010 May; 16(5):658-67. PubMed ID: 20440775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [IV Consensus meeting of the Spanish Society of Liver Transplantation (SETH) 2012. Liver transplant with non-conventional grafts: Split liver transplantation and non-heart beating donors].
    Abradelo M; Fondevila C;
    Cir Esp; 2014 Mar; 92(3):157-67. PubMed ID: 24369829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spanish society of liver transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation.
    Berenguer M; Charco R; Manuel Pascasio J; Ignacio Herrero J
    Liver Int; 2012 May; 32(5):712-31. PubMed ID: 22221843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consensus document from the Spanish Society for Liver Transplantation: Enhanced recovery after liver transplantation.
    Lladó L; Abradelo de Usera M; Blasi A; Gutiérrez R; Montalvá E; Pascual S; Rodríguez-Laiz G;
    Gastroenterol Hepatol; 2024 Feb; 47(2):206-217. PubMed ID: 38342510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consensus document from the Spanish Society for Liver Transplantation: enhanced recovery after liver transplantation.
    Lladó L; Usera MA; Blasi A; Gutiérrez R; Montalvá E; Pascual S; Rodríguez-Laiz G;
    Cir Esp (Engl Ed); 2024 Feb; 102(2):104-115. PubMed ID: 38403385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the management of the liver transplant patient.
    Kwong AJ; Fix OK
    Curr Opin Gastroenterol; 2015 May; 31(3):224-32. PubMed ID: 25774445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver transplant recipient selection: MELD vs. clinical judgment.
    Fink MA; Angus PW; Gow PJ; Berry SR; Wang BZ; Muralidharan V; Christophi C; Jones RM
    Liver Transpl; 2005 Jun; 11(6):621-6. PubMed ID: 15915491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a dropout assessment model of candidates with/without hepatocellular carcinoma on a common liver transplant waiting list.
    Toso C; Majno P; Berney T; Morel P; Mentha G; Combescure C
    Transpl Int; 2014 Jul; 27(7):686-95. PubMed ID: 24649861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MELDEQ : An alternative Model for End-Stage Liver Disease score for patients with hepatocellular carcinoma.
    Marvin MR; Ferguson N; Cannon RM; Jones CM; Brock GN
    Liver Transpl; 2015 May; 21(5):612-22. PubMed ID: 25694099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intention to treat outcome of T1 hepatocellular carcinoma with the "wait and not ablate" approach until meeting T2 criteria for liver transplant listing.
    Mehta N; Sarkar M; Dodge JL; Fidelman N; Roberts JP; Yao FY
    Liver Transpl; 2016 Feb; 22(2):178-87. PubMed ID: 26479422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Orthotopic liver transplantation (first clinical experience)].
    Konstantinov BA; Eramishantsev AK; Goté SV; Tsirulńikova OM; Skipenko OG; Lebezev VM; Shertsinger AG; Lokshin LS
    Khirurgiia (Mosk); 1993 Mar; (3):32-44. PubMed ID: 8089967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.